Effects of Ranitidine on pulmonary function tests of patients with chronic obstructive pulmonary disease

Hasanoglu H., Yidirim Z., Hasanoglu A., Ozcan C., Gokirmak M., Koksal N., ...Daha Fazla

PHARMACOLOGICAL RESEARCH, cilt.47, sa.6, ss.535-539, 2003 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 47 Sayı: 6
  • Basım Tarihi: 2003
  • Doi Numarası: 10.1016/s1043-6618(03)00012-4
  • Dergi Adı: PHARMACOLOGICAL RESEARCH
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.535-539
  • İnönü Üniversitesi Adresli: Hayır

Özet

Since the incidence of peptic ulcer and gastroesophageal reflux (GER) is more common in patients with chronic obstructive pulmonary disease (COPD) than normal population, H-2 receptor blockers are given more extensively to COPD patients. This study evaluated the effects of Ranitidine on pulmonary function tests (PFT) of the patients having COPD and peptic ulcer or GER, and of healthy volunteers.